We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Ends Development of Cholesterol-Lowering Drug NKS104
Novartis Ends Development of Cholesterol-Lowering Drug NKS104
December 16, 2005
Novartis has terminated development of an experimental cholesterol-lowering drug after clinical studies showed the treatment was not more effective than existing medications.